← Retour à la une
États-Unis · Plateformes & données · Yahoo Finance

Astromech Acquires Form Bio, Bringing Together Evolutionary AI and Genetic Medicine Design Under One Directive

Publié par Yahoo Finance · États-Unis il y a 8 h
Astromech Acquires Form Bio, Bringing Together Evolutionary AI and Genetic Medicine Design Under One Directive
Yahoo Finance

Résumé détaillé

Astromech, an AI company developing predictive models of biological change, today announced the acquisition of Form Bio in an all-stock transaction valued at $230 million. The acquisition brings Form Bio's intellectual property, selected contracts and assets, and team into Astromech, combining evolutionary modeling with tools for designing genetic medicines and improving their manufacturability.

The combined company takes researchers from evolutionary insight to tested genetic constructs, with applications in human therapeutics, genome engineering, and animal health

DALLAS, Nov. 17, 2026 /PRNewswire/ -- Astromech, an AI company developing predictive models of biological change, today announced the acquisition of Form Bio in an all-stock transaction valued at $230 million. The acquisition brings Form Bio's intellectual property, selected contracts and assets, and team into Astromech, combining evolutionary modeling with tools for designing genetic medicines and improving their manufacturability.

The combination brings together Astromech's use of evolutionary data to predict biological function with Form Bio's tools for designing genetic medicines that researchers can build and test. DNA sequences conserved across hundreds of millions of years can offer clues to important biological functions and inform therapeutic design. By connecting those insights with design capabilities, the companies aim to help researchers address quality challenges earlier in development, reducing unwanted components at the design stage and potentially lessening the need for downstream purification.

Andrew Busey, Form Bio's co-founder and former CEO, has been named Chief AI Officer and Head of Technology at Astromech.

"Form Bio began by solving the computational challenges discovered from de-extinction and has grown into a company building foundation models for the design of human therapeutics," said Busey. "Our work with customers and partners has shaped that evolution, moving us from analyzing biological data to helping design genetic medicines. Joining Astromech gives us the opportunity to build on that progress, bringing evolutionary insights into the design decisions we help researchers make."

Astromech's models draw on data across species and evolutionary time to understand how biological functions emerged and predict how they may change.

Form Bio has spent years building foundation…

Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

À lire aussi